Journal: Cancers
Article Title: CK2 Activity Mediates the Aggressive Molecular Signature of Glioblastoma Multiforme by Inducing Nerve/Glial Antigen (NG)2 Expression
doi: 10.3390/cancers13071678
Figure Lengend Snippet: CK2 inhibition reduces NG2 expression in human GBM cell lines. ( A ) A1207 and U87 cells were treated with vehicle (DMSO) or CX-4945 (10 µM) for 72 h. The cells were lysed and the expression of NG2, Akt, pAkt S129 , CK2α, CK2α’, CK2β and α-tubulin (as loading control) was analyzed by western blot. ( B – E ) A1207 and U87 cells were treated as described in ( A ) and the expression of pAkt/Akt ( B , C ) and NG2 ( D , E ) was quantitatively analyzed. Vehicle-treated cells were set 100%. Mean ± SD. * p < 0.05 vs. vehicle ( n = 3). ( F , G ) A1207 and U87 cells were treated as described in ( A ), scratched and the mean fluorescence intensity (MFI) of NG2-positive cells was assessed by flow cytometry. The MFI of vehicle-treated cells was set 100%. Mean ± SD. * p < 0.05 vs. vehicle ( n = 4). ( H ) A1207 and U87 wild type and CK2α KO cells were lysed and the expression of NG2, Akt, pAkt S129 , CK2α, CK2α’, CK2β and α-tubulin (as loading control) was analyzed by western blot. ( I – N ) A1207 and U87 cells were treated as described in ( H ) and the expression of CK2α ( I , J ), pAkt/Akt ( K , L ) and NG2 ( M , N ) was quantitatively assessed. Wild type cells were set 100%. Mean ± SD. * p < 0.05 vs. wild type (A1207: n = 4; U87: n = 5). ( O ) A1207 wild type and CK2α KO cells were lysed and the expression of FAK, pFAK and α-tubulin (as loading control) was analyzed by western blot. ( P ) A1207 wild type and CK2α KO cells were lysed and the expression of pFAK/FAK was quantitatively assessed. Wild type cells were set 100%. Mean ± SD. * p < 0.05 vs. wild type ( n = 3).
Article Snippet: Roswell Park Memorial Institute (RPMI) 1640 medium, Dulbecco’s Modified Eagle’s Medium (DMEM), Lipofectamine3000 reagent, Opti-MEM Reduced Serum Medium (Gibco), fetal calf serum (FCS), penicillin-streptomycin and small interfering RNA (siRNA) duplexes directed against NG2 (ID: 146.147) were from Thermo Fisher Scientific (Karlsruhe, Germany).
Techniques: Inhibition, Expressing, Control, Western Blot, Fluorescence, Flow Cytometry